Ketamine One's psychedelic psychotherapy will utilize OVR's related platform, equipped with a virtual reality fragrance device that can release fragrance. Its design function is to enhance immersion, promote relaxation, and help patients cope with stress.

The platform consists of multiple components: a head mounted display screen, ION devices, fragrance boxes, and multiple natural scenes centered around fragrance. ION is a lightweight wireless device that can release fragrance particles in conjunction with virtual reality technology, enhancing the immersive experience for patients.

The fragrance used by ION is in liquid form, and its ingredients have undergone extensive experimental testing, including both natural and synthetic fragrances.

The virtual reality technology that was well-known in the past often only combined visuals and sound. Through this collaboration, Ketamine One's clinics will incorporate fragrances to create a more realistic immersive virtual reality scene, which is expected to enhance the patient experience and improve treatment outcomes.

The concept behind OVR's "Fragrance Architecture" platform and ION equipment is that fragrances in virtual reality can significantly enhance immersion. In computer simulation scenarios, patients can interact with virtual 3D environments. And with the addition of fragrance, these simulated scenes will place patients in a stable environment, enhancing their relaxation mood.

Aaron Vyshinewski, CEO and co-founder of OVR

Our virtual reality platform is the first to understand users' behavior in the virtual world and simulate sensory environments in real time for response. It has great potential and is expected to enable this already promising technology to have a greater medical impact